Maravai LifeSciences Holdings, Inc. MRVI Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Maravai LifeSciences Holdings, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s debt-to-equity?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported debt-to-equity of 1.3× in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s debt-to-equity changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s debt-to-equity increased by 17.8% year-over-year, from 1.1× to 1.3×.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s debt-to-equity?
- Over 5 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s debt-to-equity has grown at a -23.8% compound annual growth rate (CAGR), from 6.7× to 1.7×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.